Impact of enhanced external counterpulsation on heart failure rehospitalization in patients with ischemic cardiomyopathy

Kristen M. Tecson, Marc A. Silver, Sonja D Brune, Clay Cauthen, Michael D. Kwan, Jeffrey M. Schussler, Anupama Vasudevan, James A. Watts, Peter A. McCullough

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Heart failure (HF) affects millions of Americans and causes financial burdens because of the need for rehospitalization. For this reason, health care systems and patients alike are seeking methods to decrease readmissions. We assessed the potential for reducing readmissions of patients with postacute care HF through an educational program combined with enhanced external counterpulsation (EECP). We examined 99 patients with HF who were referred to EECP centers and received heart failure education and EECP treatment within 90 days of hospital discharge from March 2013 to January 2015. We compared observed and predicted 90-day readmission rates and examined results of 6-minute walk tests, Duke Activity Status Index, New York Heart Association classification, and Canadian Cardiovascular Society classification before and after EECP. Patients were treated with EECP at a median augmentation pressure of 280 mm Hg (quartile 1 = 240, quartile 3 = 280), achieved as early as the first treatment. Augmentation ratios varied from 0.4 to 1.9, with a median of 1.0 (quartile 1 = 0.8, quartile 3 = 1.2). Only 6 patients (6.1%) had unplanned readmissions compared to the predicted 34%, p

Original languageEnglish (US)
Pages (from-to)901-905
Number of pages5
JournalAmerican Journal of Cardiology
Volume117
Issue number6
DOIs
StatePublished - Mar 15 2016

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Tecson, K. M., Silver, M. A., Brune, S. D., Cauthen, C., Kwan, M. D., Schussler, J. M., Vasudevan, A., Watts, J. A., & McCullough, P. A. (2016). Impact of enhanced external counterpulsation on heart failure rehospitalization in patients with ischemic cardiomyopathy. American Journal of Cardiology, 117(6), 901-905. https://doi.org/10.1016/j.amjcard.2015.12.024